Intervention not reported
Overall survival: 3‐year survival rate · stages I to III NSCLC patients treated with surgery or radiotherapy with curative intent
The intervention showed no clear difference in overall survival: 3‐year survival rate (moderate certainty).
1 finding from 1 review
- Immunotherapy (excluding checkpoint inhibitors) for stage I to III non‐small cell lung cancer treated with surgery or… 2021 · Cochrane Headline outcomes onlyRR 0.99 [0.9, 1.09]7 studies · 4420 participantsModerate